MC
WST icon

Machina Capital’s West Pharmaceutical WST Stock Holding History

Machina Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,270
Closed -$486K – 374
2023
Q2 		$486K Buy
+1,270
New +$454K 0.28% 146
2019
Q4 		– Sell
-2,999
Closed -$425K – 444
2019
Q3 		$425K Buy
2,999
+2,665
+798% +$367K 0.19% 173
2019
Q2 		$42K Buy
+334
New +$39.4K 0.02% 421

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Machina Capital's WST Position: Q3 2023 in Review

Machina Capital sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 1,270 shares — an estimated $486K sold.

Machina Capital first reported a position in WST in Q2 2019 and held it in 3 quarters. The position peaked at $486K in Q2 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Machina Capital reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Machina Capital sold 1,270 West Pharmaceutical shares in Q3 2023, an estimated $486K.
  • Machina Capital first reported a position in West Pharmaceutical in Q2 2019 and held it in 3 quarters.
  • Machina Capital's West Pharmaceutical position peaked at $486K in Q2 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Machina Capital's 13F filing for Q3 2023, filed 3 Nov 2023.